CD38 in hematopoietic malignancies.
Konopleva
M
M
Department of Blood and Marrow Transplantation, University of Texas M.D. Anderson Cancer Center, Houston, USA.
Rissling
I
I
Andreeff
M
M
D036541:ADP-ribosyl Cyclase; D051997:ADP-ribosyl Cyclase 1; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D017209:Apoptosis; D005786:Gene Expression Regulation; D006410:Hematopoiesis; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000209:etiology; D008562:Membrane Glycoproteins; D009097:Multienzyme Complexes / Q000502:physiology*; D009244:NAD+ Nucleosidase / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D014212:Tretinoin / Q000502:physiology
D015703:Antigens, CD; D000943:Antigens, Differentiation; D000922:Immunotoxins; D008562:Membrane Glycoproteins; D009097:Multienzyme Complexes; D014212:Tretinoin; D036541:ADP-ribosyl Cyclase; C498154:CD38 protein, human; D009244:NAD+ Nucleosidase; D051997:ADP-ribosyl Cyclase 1